REHOVOT, Israel , Oct. 16, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing disruptive technologies and products based on its...
CollPlant is now moving towards clinical trials and scaling and optimizing its manufacturing to ensure readiness for the upcoming clinical trials
REHOVOT, Israel , Sept. 15, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), or ' CollPlant ' , a regenerative and aesthetics medicine company developing innovative...
REHOVOT, Israel , Aug. 25, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing disruptive technologies and...
- Sales of rhCollagen and bioinks primed for augmentation following new U.S.-based commercial executive hire -